30 August 2022 : Original article
Clinical Validation of a Novel Scoring System Based on Donor and Recipient Risk Factors for Predicting Outcomes in Liver Transplantation
Lucas Souto Nacif1ABCDEF*, Daniel Reis Waisberg1CDE, Leonardo Yuri Zanini1BCDEF, Rafael Soares Pinheiro1ACD, Vinicius Rocha-Santos1ACD, Rubens Arantes Macedo1BD, Liliana DucattiDOI: 10.12659/AOT.936271
Ann Transplant 2022; 27:e936271
Table 4 COX regression analysis (validation group – 70% bank randomly selected).
| Coefficient | Risk | SD | IC 95% | Wald teste | p-value | |
|---|---|---|---|---|---|---|
| Retransplant | −17 | 1.60 | 0.29 | 3.6e-08 (0-Inf) | 0 | 0.99 |
| Fulminant hepatitis | 0.66 | 0.20 | 0.23 | 1.90 (1.30–2.90) | 11 | <0.001 |
| Large surgery/biliary tree surgery | 0.45 | 0.21 | 0.21 | 1.60 (1.10–2.40) | 4.9 | 0.03 |
| MELD (24–29) | 0.26 | 1.30 | 0.77 | 1.30 (0.70–2.23) | 25.6 | 0.34 |
| MELD (29–35) | 0.51 | 1.66 | 0.60 | 1.66 (1.12–2.46) | 25.6 | 0.01 |
| MELD (>35) | 0.90 | 2.46 | 0.41 | 2.46 (1.72–3.54 | 25.6 | <0.001 |
| Creatinine before transplant >1.5 mg/dL | 0.77 | 0.15 | 0.46 | 2.20 (1.60–2.90) | 26 | <0.001 |
| SD – standard deviation; IC – confidence index; MELD – model of end stage liver disease. Log-rank demonstrated p | ||||||






